New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2014
06:17 EDTBAYRYBayer to acquire Dihon Pharmaceutical Group in China
Bayer plans to acquire 100% of the shares of Dihon Pharmaceutical Group Co., Ltd., Kunming Yunnan, China, a privately held pharmaceutical company specializing primarily in over-the-counter and herbal traditional Chinese medicine products. Dihon is a player in China's OTC industry with products such as Kang Wang for the treatment of dandruff and other scalp disorders and Pi Kang Wang, an antifungal cream, as well as TCM product Dan E Fu Kang for the treatment of various women's health indications. Financial details have not been disclosed. The transaction is subject to fulfillment of certain conditions, including merger control clearance, and is expected to close in the second half of 2014.
News For BAYRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
05:25 EDTBAYRYRegeneron reports approval of Eylea by Japan
Subscribe for More Information
June 25, 2015
14:01 EDTBAYRYBayer initiated with a Buy at HSBC
Subscribe for More Information
08:00 EDTBAYRYBayer to hold a meeting
Subscribe for More Information
June 23, 2015
10:31 EDTBAYRYMonsanto says Bayer crop chemicals unit an option, Bloomberg reports
Subscribe for More Information
June 16, 2015
06:23 EDTBAYRYAcura enters into agreement with Pharma Bayer for IMPEDE
Acura Pharmaceuticals (ACUR) announced that Acura has entered into a License and Development Agreement with Bayer Healthcare (BAYRY) to provide an exclusive worldwide license to Acura's IMPEDE technology for use in an undisclosed methamphetamine resistant pseudoephedrine containing product and to jointly develop such product utilizing the IMPEDE technology for the U.S. market. Bayer has the right to negotiate for a worldwide license to the IMPEDE technology for additional products.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use